header-bg-analysis-01.jpg

Preclinical Imaging and Analysis Services

GemPharmatech provides preclinical imaging and analysis services using dual-energy X-ray absorptiometry (DEXA), in vivo optical imaging, ultrasound, and blood flow analysis. These noninvasive technologies support longitudinal assessment of disease progression, drug efficacy, body composition, cardiovascular function, and other physiological changes.
icon-arrow-g
Imaging Capabilities
Preclinical Imaging and Analysis Services

Dual-Energy X-ray Absorptiometry (DEXA)

High-resolution Bone Density Assessment

High-resolution X-ray scanning enables whole-body and regional assessment of bone mineral density and changes in bone structure, supporting efficacy evaluation in osteoporosis and other bone metabolism studies.

Body Composition Analysis

Quantitative analysis of fat mass, lean tissue, and body composition helps distinguish the sources of weight change and evaluate treatment effects in metabolic disease studies.

In Vivo and Ex Vivo Imaging

DEXA supports both in vivo animal imaging and ex vivo tissue analysis, enabling researchers to correlate longitudinal phenotypic changes with tissue-level findings.

Longitudinal Studies

Noninvasive imaging enables repeated measurements in the same animals over time, supporting longitudinal analysis while potentially reducing the number of animals required.

In Vivo Optical Imaging

The in vivo optical imaging system captures and quantifies bioluminescent and fluorescent signals in living organisms, enabling real-time, non-invasive monitoring of tumor progression, metastatic spread, drug distribution, and various physiological processes in mouse models. The platform supports drug efficacy evaluation and pharmacokinetic analysis.

Ultrasound Imaging and Analysis

Cardiac Ultrasound Imaging

Cardiac Structure Assessment: High-resolution ultrasound imaging measures parameters including left ventricular internal diameter and ventricular wall thickness to assess cardiac size and structure.

Cardiac Function Assessment: Measurement of parameters including left ventricular ejection fraction and fractional shortening supports evaluation of systolic and diastolic cardiac function.

Organ Ultrasound Imaging

Liver Ultrasound: Assessment of liver size, shape, and internal echogenicity supports the detection and evaluation of liver abnormalities.

Kidney Ultrasound: Assessment of kidney size, cortical thickness, and structural abnormalities such as hydronephrosis supports evaluation of renal structure.

Blood Flow Analysis

Carotid Artery Blood Flow Detection: Coronary artery blood flow measurements support cardiovascular disease studies and evaluation of therapeutic effects.

Coronary Artery Blood Flow Detection: Echocardiography enables measurement of coronary artery blood flow to support cardiovascular disease research and evaluation of therapeutic effects.

Noninvasive Blood Pressure Measurement

Tail Artery Blood Pressure Measurement: Noninvasive tail artery measurement enables longitudinal monitoring of blood pressure in mice, including changes associated with drug intervention and disease progression.

 Ultrasound Data Analysis

The ultrasound analysis platform provides high-precision image recognition and quantitative data analysis. Measurements including organ dimensions and hemodynamic parameters support detailed assessment of cardiovascular function and organ status in mouse models.


Platform Technology
Preclinical Imaging Platforms and Technical Capabilities
GemPharmatech combines advanced imaging technologies to support noninvasive, longitudinal assessment in preclinical studies. Our platforms provide quantitative data on bone density, body composition, tumor progression, drug distribution, cardiovascular function, blood flow, and other physiological parameters.
  • Dual-Energy X-ray Absorptiometry (DEXA) Platformicon-arrow-g

    ①  Platform Advantages

    • Precision: High-resolution measurement of bone mineral density and body composition

    • Noninvasive Analysis: Minimal animal handling for repeated measurements

    • Reproducibility: Consistent data across longitudinal studies

    • Image Quality: High-resolution imaging for detailed anatomical and body composition analysis

    ②  Imaging Capabilities

    The system generates comprehensive imaging outputs, including high-resolution X-ray images, bone mineral density (BMD) maps, and pseudo-colored body composition visualizations enabling multi-dimensional analysis in a single scan.

    • X-Ray Imaging: High-resolution radiographs support precise measurement of regional bone length, fracture assessment, and implant localization with exceptional clarity.

    • Bone Mineral Density Mapping: Quantitative BMD visualization highlights density distribution across skeletal regions, facilitating early detection of bone loss and treatment response evaluation.

    • Body Composition Analysis: Pseudo-colored imaging distinguishes fat, lean tissue, and bone mass, providing an intuitive overview of physiological changes in metabolic and aging studies.

    X-ray imagesBMD  ImagesBMD  Images


    BMD

    BMC

    Bone Area

    Tissue Area

    Fat(%%)

    Fat(g)

    Lean(g)

    0.087

    0.553

    6.33

    16.507

    14.104

    3.294

    20.061

    Isolated bone tissue

    BMD

    BMC

    Bone Area

    Tissue Area

    Fat(%)

    Fat(g)

    Lean(g)

    0.034

    0.001

    0.017

    0.267

    4

    0.005

    0.128

    0.016

    0.004

    0.22

    3.181

    32.037

    0.591

    1.253


  • <i>In Vivo</i> Optical Imaging Platformicon-arrow-g

    ①  Platform Advantages

    • Broad Coverage: Large field of view for simultaneous imaging of multiple regions

    • High Throughput: Multi-animal imaging for efficient study execution

    • Multimodal Imaging: Integrated fluorescence and bioluminescence capabilities

    • Quantitative Analysis: Absolute signal intensity quantification for rigorous data analysis

    ②  Imaging and Analysis Capabilities

    In vivo optical imaging enabled real-time monitoring of drug distribution, accumulation, and clearance in live animals across multiple time points.


  • Ultrasound and Cardiovascular Imaging Platformicon-arrow-g

    ① Noninvasive Blood Pressure Measurement: Kent CODA system


    ② Small-Animal Ultrasound Imaging: VINNO VINNOD8 LAB system


    ③ Animal Electrophysiology: ADInstruments system



    ④ Laser Speckle Blood Flow Imaging: RWD RFLSI system


zimg7.png

Ready to Accelerate Your Research?

Recommended Content
close

Submit Inquiry

First Name*

Last Name*

Organization*

Email*

Country/Region*

Select Country/Region

State/Province*

City

Area of interest*

Select Area of Interest

Research Focus

Additional Info

Submitarrowarrow

Contact Us

First Name*

Last Name*

Organization*

Email*

Country/Region*

Select Country/Region

State/Province*

City

Area of interest*

Select Area of Interest

Research Focus

How did you hear about us*

Select a source

Leave us a message*

Submitarrowarrow

Schedule a Meeting

Let us know which event you're attending and we'd be happy to connect with you.

First Name*

Last Name*

Organization*

Email*

Country/Region*

Select Country/Region

State/Province*

City

Area of interest*

Select Area of Interest

Research Focus

How did you hear about us*

Select a source

Leave us a message

Submitarrowarrow

Download

First Name*

Last Name*

Organization*

Email*

Country/Region*

Select Country/Region

State/Province*

City

Research Focus

Submitarrowarrow

Download

First Name*

Last Name*

Organization*

Email*

Country/Region*

Select Country/Region

State/Province*

City

Research Focus

Submitarrowarrow

Watch On-Demand Webinar

First Name*

Last Name*

Organization*

Email*

Country/Region

Select Country/Region

State/Province*

City

Research Focus

Submitarrowarrow

Newsletter Signup

First Name*

Last Name*

Organization*

Email*

Country/Region*

Select Country/Region

Area of interest*

Select Area of Interest

Research Focus

Submitarrowarrow